True but based on my extensive research the Medgate news should have push the pps back to 10c, they will only bring in at most $2M revenue but the key was that a leader in telehealth for 20+ years and one of the biggest in Europe did an extensive 5 months commercial pilot in ResAppDx in real world environment.
RAP Price at posting:
7.2¢ Sentiment: Buy Disclosure: Held
